Categories: Uncategorized

Avinger to Present at Oppenheimer Healthcare Conference on March 20

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced today announced that Jeff Soinski, CEO, will present at the Oppenheimer & Co. 29th Annual Healthcare Conference on Wednesday, March 20, 2019, at 1:00 pm Eastern Time, at the Westin New York Grand Central in New York City.

Management will be available to meet with investors throughout the day on Wednesday, March 20. Investors wishing to schedule a meeting should contact Oppenheimer & Co. or Avinger Investor Relations at mkreps@darrowir.com.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Investor Contact:

Mark Weinswig
Chief Financial Officer
Avinger, Inc.
(650) 241-7916
ir@avinger.com

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.

View source version on accesswire.com:
https://www.accesswire.com/537428/Avinger-to-Present-at-Oppenheimer-Healthcare-Conference-on-March-20

user

Share
Published by
user

Recent Posts

LEGACY EDUCATION INC. ACHIEVES RECORD Q3 WITH 50% REVENUE GROWTH AND SURPASSES 3,000 ENROLLED STUDENTS

LANCASTER, Calif., May 15, 2025 /PRNewswire/ -- Legacy Education Inc. (NYSE American: LGCY), a leading…

11 hours ago

BrainStorm Cell Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update

Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW…

11 hours ago

MediKarma Aligns with CMS National Preventive Health Strategy Through AI-Driven, Prevention-First Implementation Infrastructure

SAN FRANCISCO, May 15, 2025 /PRNewswire/ -- MediKarma, a digital health company specializing in AI-powered…

11 hours ago

Dentegrate AI Powers Growth for 220+ Dental Practices, Doubling New Patient Acquisition

BOSTON, May 15, 2025 /PRNewswire/ -- Dentegrate AI is revolutionizing dental practice growth, with over…

11 hours ago

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating…

12 hours ago

cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May…

12 hours ago